financetom
TIMB
financetom
/
Communication Services
/
TIMB
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
TIM S.A.TIMB
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

TIM S.A., a telecommunications company, provides mobile voice, data, and broadband services in Brazil.

The company offers in mobile, landline, long-distance, and data transmission services. It also offers ultra-broadband, digital content, and tailored packages services.

The company serves individuals and corporates, as well as small, medium, and large companies. TIM S.A is founded in 2013 and is based in Rio de Janeiro, Brazil.

The company operates as a subsidiary of TIM Brasil Serviços e Participações S.A.

Latest News >
Whale Selling Pushes ETH/BTC to 3.5 Year Low, Where Next for Ethereum? 
Whale Selling Pushes ETH/BTC to 3.5 Year Low, Where Next for Ethereum? 
Sep 16, 2024
Ethereum is at its weakest level against Bitcoin since early 2021 as the ETH/BTC ratio continues to break down. The ratio is a measure of the price of ETH in Bitcoin terms, not in US dollars. Despite falling 21% from its all-time high, Bitcoin has remained robust, whereas Ethereum remains down 53% from its peak in 2021. In a post...
US STOCKS-Futures muted in cautious start to Fed meeting week
US STOCKS-Futures muted in cautious start to Fed meeting week
Sep 16, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Intel ( INTC ) rises after report chipmaker qualifies for federal grants * Alcoa ( AA ) up after announcing stake sale in Ma'aden joint venture * Futures: Dow up 0.21%, S&P 500 up 0.03%, Nasdaq off 0.20% (Updated...
Johnson & Johnson Says its Bladder Cancer Drug Combined With Cetrelimab Shows High Response Rate in Study
Johnson & Johnson Says its Bladder Cancer Drug Combined With Cetrelimab Shows High Response Rate in Study
Sep 16, 2024
07:42 AM EDT, 09/16/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday interim results from its phase 2 study of its experimental bladder cancer therapy, TAR-200, showed in combination with chemotherapy using cetrelimab, TAR-200 demonstrated a nearly double pathologic complete response to using chemotherapy alone on patients with muscle-invasive bladder cancer. Treatment-related adverse events occurred in 72%...
INDIA BONDS-Massive Fed rate-cut bets push India bond yields down for fourth day
INDIA BONDS-Massive Fed rate-cut bets push India bond yields down for fourth day
Sep 16, 2024
MUMBAI, Sept 16 (Reuters) - Indian government bond yields declined for the fourth consecutive session on Monday, as bets of a bigger rate cut from the U.S. Federal Reserve later this week further powered the bulls. The benchmark 10-year yield ended at 6.7613%, its lowest since Feb. 25 2022 and less than its previous close of 6.7904%. A scheduled debt...
Copyright 2023-2026 - www.financetom.com All Rights Reserved